Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 4Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 3Spondylarthritis 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Tumor Necrosis Factor Inhibitors × Clear all
NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

NCT04529902 2021-11-23

DREAM

Brigham and Women's Hospital

Completed
63,013 enrolled

Arthritis, Rheumatoid

NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase 4 Completed
31 enrolled

Spondylarthritis

NCT01548768 2020-11-27

RHYTHM

Columbia University

Phase 4 Completed
149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡